期刊簡(jiǎn)介預(yù)計(jì)審稿時(shí)間： 較慢,6-12周

Current Vascular Pharmacology publishes clinical and research-based reviews/mini-reviews, original research articles, letters, debates, drug clinical trial studies and guest edited issues to update all those concerned with the treatment of vascular disease, bridging the gap between clinical practice and ongoing research.

Vascular disease is the commonest cause of death in Westernized countries and its incidence is on the increase in developing countries. It follows that considerable research is directed at establishing effective treatment for acute vascular events. Long-term treatment has also received considerable attention (e.g. for symptomatic relief). Furthermore, effective prevention, whether primary or secondary, is backed by the findings of several landmark trials. Vascular disease is a complex field with primary care physicians and nurse practitioners as well as several specialties involved. The latter include cardiology, vascular and cardio thoracic surgery, general medicine, radiology, clinical pharmacology and neurology (stroke units).

《當(dāng)代血管藥理學(xué)》發(fā)表臨床和研究綜述/小綜述、原創(chuàng)研究文章、信件、辯論、藥物臨床試驗(yàn)研究和特邀編輯的問(wèn)題，以更新所有關(guān)注血管疾病治療的人，彌合臨床實(shí)踐與正在進(jìn)行的研究之間的差距。

血管疾病是西方國(guó)家最常見(jiàn)的死亡原因，其發(fā)病率在發(fā)展中國(guó)家呈上升趨勢(shì)。因此，大量研究旨在建立有效的急性血管事件治療方法。長(zhǎng)期治療也受到了廣泛關(guān)注（例如用于緩解癥狀）。此外，有效的預(yù)防，無(wú)論是初級(jí)還是次級(jí)的，都得到了幾項(xiàng)具有里程碑意義的試驗(yàn)結(jié)果的支持。血管疾病是一個(gè)復(fù)雜的領(lǐng)域，涉及初級(jí)保健醫(yī)生和執(zhí)業(yè)護(hù)士以及幾個(gè)專(zhuān)業(yè)。后者包括心臟病學(xué)、血管和心胸外科、普通醫(yī)學(xué)、放射學(xué)、臨床藥理學(xué)和神經(jīng)病學(xué)（卒中科）。

《Current Vascular Pharmacology》(當(dāng)前的血管藥理學(xué))編輯部通訊方式為BENTHAM SCIENCE PUBL LTD, EXECUTIVE STE Y26, PO BOX 7917, SAIF ZONE, SHARJAH, U ARAB EMIRATES, 1200 BR。如果您需要協(xié)助投稿或潤(rùn)稿服務(wù)，您可以咨詢我們的客服老師。我們專(zhuān)注于期刊咨詢服務(wù)十年，熟悉發(fā)表政策，可為您提供一對(duì)一投稿指導(dǎo)，避免您在投稿時(shí)頻繁碰壁，節(jié)省您的寶貴時(shí)間，有效提升發(fā)表機(jī)率，確保SCI檢索（檢索不了全額退款）。我們視信譽(yù)為生命，多方面確保文章安全保密，在任何情況下都不會(huì)泄露您的個(gè)人信息或稿件內(nèi)容。